Skip to content

Celcuity CELC Change in AP

Change in AP at other companies

Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Gilead Sciences logo
Gilead SciencesGILD
-$67M+36.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$7.17M-141%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$3.67M+206%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$4.24M+98.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$1.79M+9.5%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's change in AP?
Celcuity (CELC) reported change in AP of $4.08M in Q1 2026.
How has Celcuity's change in AP changed year-over-year?
Celcuity's change in AP increased by 565.6% year-over-year, from $613K to $4.08M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.